← All organizations

Sapphire Therapeutics

For profit

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

Jun 1, 2005

Acquired by Helsinn on Jan 1, 2009

Timeline

2000s

Jan 1, 2000
Sapphire Therapeutics— Founded
Jan 1, 2009
Helsinn— Acquired By

Drugs by trial phase (1 distinct, 1 trials)

Phase 2 (1 own, 0 via acquisition)

anamorelin

Indications

Studied for

Recent trials (1)

NCT00219817Study directorPhase 2Jun 1, 2005

Details

Founded: Bridgewater, NJ, US Jan 1, 2000
Last known activity: Jun 1, 2005